CTRI/2024/07/071416
Not Yet Recruiting
N/A
Effectiveness of Reach Out and Read Program on Neurodevelopment at 1 year in High risk infants A Randomized Controlled trial - NI
Ketaki Karnik0 sites0 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ketaki Karnik
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male and female Infants who visit the High Risk clinic, at tertiary care hospital, Belagavi
- •2\. Infants whose mothers are able to read and comprehend in vernacular language
- •3\. Parents who are willing to participate
Exclusion Criteria
- •1\. Infants who are critically ill.
- •2\. Infants who are referred for any surgeries in next 6 months.
- •3\. Infant with genetic disorders, congenital anomalies, metabolic diseases
- •4\. Infants with known neuromotor disabilities
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Investigation of the efficacy of read-through therapy for Nagashima-type palmoplantar keratosis using topical aminoglycosideagashima-type palmoplantar keratosisJPRN-UMIN000018677Hokkaido University Hospital6
Completed
Phase 2
Providing a comprehensive neuropsychological rehabilitation program that is focused on restoring language and cognitive deficits for patients suffering from post stroke aphasia.Health Condition 1: null- Patients suffering from 1st time ischemic stroke suffering from post-stroke aphasia.CTRI/2014/04/004554All India Institute of Medical Sciences
Completed
N/A
Reach Out and Read Literacy Programme for Neurodevelopment in High Risk InfantsCTRI/2024/01/061640KAHER instiute of physiotherapy32
Not Yet Recruiting
Phase 1
Exploratory study of a new method of plasma moxibustion for the treatment of insomniainsomniaITMCTR2200005749Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medicine Sciences
Completed
N/A
A Prospective Study to Evaluate Effectiveness of Upadacitinib in Moderate to Severe AD with Prurigo Nodules in the Real World in JapaJPRN-UMIN000048463AbbVie GK200